August 17, 2015 An Evidence-Based Drug Development Tool for Tuberculosis Regimens: The Hollow Fiber System Model
August 17, 2015 New Clinical Infectious Diseases Journal Supplement Highlights Hollow Fiber System Model for Tuberculosis New Clinical Infectious Diseases Journal Supplement Highlights Hollow Fiber System Model for Tuberculosis The achievements
August 15, 2015 Forecasting Accuracy of the Hollow Fiber Model of Tuberculosis for Clinical Therapeutic Outcomes
August 15, 2015 Strategic Regulatory Evaluation and Endorsement of the Hollow Fiber Tuberculosis System as a Novel Drug Development Tool
July 28, 2015 Correlations Between the Hollow Fiber Model of Tuberculosis and Therapeutic Events in Tuberculosis Patients: Learn and Confirm
July 27, 2015 FDA: Guidance for Industry Duchenne Muscular Dystrophy Developing Drugs for Treatment Over the Spectrum of Disease
July 23, 2015 CDISC Releases Clinical Research Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia July 23, 2015 CDISC Releases Clinical Research Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia Austin, TX – 23 Ju
July 22, 2015 Critical Path Institute Establishes The Global Pediatric Clinical Trials Network Pre-Launch Consortium July 22, 2015 Critical Path Institute Establishes The Global Pediatric Clinical Trials Network Pre-Launch Con
